Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Barclays PLC Capital/Financing Update 2016

Nov 28, 2016

5250_rns_2016-11-28_ef40e902-f3b5-47a1-bca5-d9fbefc008ba.pdf

Capital/Financing Update

Open in viewer

Opens in your device viewer

BARCLAYS BANK PLC

(Incorporated with limited liability in England and Wales)

GBP 12,000,000 Warrant Linked Securities due November 2022 pursuant to the Global Structured Securities Programme (the "Tranche 1 Securities")

Issue Price: 100 per cent.

This document constitutes the final terms of the Securities (the "Final Terms") described herein for the purposes of Article 5.4 of the Prospectus Directive and is prepared in connection with the Global Structured Securities Programme established by Barclays Bank PLC (the "Issuer"). This Final Terms is supplemental to and should be read in conjunction with the GSSP Base Prospectus 5 dated 10 June 2016, as supplemented on 23 August 2016 (the "Base Prospectus"), which constitutes a base prospectus for the purposes of the Prospectus Directive. Full information on the Issuer and the offer of the Securities is only available on the basis of the combination of this Final Terms and the Base Prospectus. A summary of the individual issue of the Securities is annexed to this Final Terms. Words and expressions defined in the Base Prospectus and not defined in the Final Terms shall bear the same meanings when used herein.

The Base Prospectus, and any supplements thereto, are available for viewing at http://irreports.barclays.com/prospectuses-and-documentation/structured-securities/prospectuses and during normal business hours at the registered office of the Issuer and the specified office of the Issue and Paying Agent for the time being in London, and copies may be obtained from such office.

BARCLAYS

Final Terms dated 29 November 2016

PART A – CONTRACTUAL TERMS

1. (a) Series number: NX000186544
(b) Tranche number: 1
2. Currency: Pounds Sterling ("GBP")
3. Securities:
(a) Aggregate Nominal Amount as at
the Issue Date:
(i)
Tranche:
GBP 12,000,000
(ii) Series: GBP 12,000,000
(b) Specified Denomination: GBP 1.00
(c) Minimum Tradable Amount: Not Applicable
(d) Calculation Amount: GBP 1.00
4. Issue Price: 100% of par.
5. Issue Date: 29 November 2016
6. Scheduled Redemption Date: 29 November 2022
7. Warrant linked Securities:
(a) Underlying Warrant(s) and
Underlying Warrant Reference
Asset(s):
Warrant (an "Underlying Warrant") linked to the
FTSE 100 Index
(an "Underlying
Warrant
Reference Asset") issued by Barclays Bank PLC
(ISIN:
GB00B8MNRK12;
Series
number:
NX000186545)
(b) Final Valuation Date: 22 November 2022, subject as specified in General
Condition 5.3 (Relevant defined terms)
(c) Valuation Time: As specified in General Condition 5.3 (Relevant
defined terms)
8. Additional Disruption Event:
(a) Change in Law Not Applicable
(b) Currency Disruption Event: Applicable
as
per
General
Condition
22.1
(Definitions)
(c) Issuer Tax Event: Applicable
as
per
General
Condition
22.1
(Definitions)
(d) Extraordinary Market Disruption: Applicable
as
per
General
Condition
22.1
(Definitions)
9. Form of Securities: Bearer Securities
Permanent Global Security
NGN Form: Applicable
CGN Form: Not Applicable
CDIs: Not Applicable
10. Trade Date: 22 November 2016
11. Early Redemption Notice Period
Number:
As
specified
in
General
Condition
22.1
(Definitions)
12. Additional Business Centre(s): Not Applicable
13. Determination Agent: Barclays Bank PLC
14. (a) Name of Manager: Barclays Bank PLC
(b) Date of underwriting agreement: Not Applicable

PART B - OTHER INFORMATION

1. LISTING AND ADMISSION TO TRADING

Application is expected to be made by the Issuer (or on its behalf) for the Securities to be listed on the Official List and admitted to trading on the Regulated Market of the London Stock Exchange on or around the Issue Date.

2. RATINGS

Ratings: The Securities have not been individually rated.

3. INTERESTS OF NATURAL AND LEGAL PERSONS INVOLVED IN THE OFFER

Save for any trading and market-making activities of the Issuer and/or its affiliates in the Underlying Warrant the hedging activities of the Issuer and/or its affiliates and the fact that the Issuer is the Determination Agent in respect of the Securities and the Determination Agent in respect of the Underlying Warrants, so far as the Issuer is aware, no person involved in the offer of the Securities has an interest material to the offer.

4. REASONS FOR THE OFFER, ESTIMATED NET PROCEEDS AND TOTAL EXPENSES

  • (a) Reasons for the offer: Making profit and/or hedging purposes
  • (b) Estimated net proceeds: Not Applicable
  • (c) Estimated total expenses: Not Applicable

5. PERFORMANCE OF THE UNDERLYING WARRANTS AND OTHER INFORMATION CONCERNING THE UNDERLYING WARRANTS

The value of the Securities will depend upon the performance of the Underlying Warrant which is:

A Warrant linked to the FTSE 100 Index issued by Barclays Bank PLC (ISIN: GB00B8MNRK12; Series number: NX000186545).

The Warrant Value of the Underlying Warrant will be published on each Business Day on GB00B8MNRK12=RIC.

Details of the past performance and volatility of the Underlying Warrant Reference Asset may be obtained from Reuters page .FTSE. The terms and conditions of the Underlying Warrant are available on http://group.barclays.com/prospectuses-anddocumentation/structured-securities/final-terms.

Index disclaimer: FTSE® 100 Index

6. OPERATIONAL INFORMATION

  • (a) ISIN Code: XS1452796078
  • (b) Common Code: 145279607
  • (c) Name(s) and address(es) of any clearing system(s) other than Euroclear Bank S.A./N.V. and Clearstream Banking, société anonyme, and the relevant identification number(s): Not Applicable

7. TERMS AND CONDITIONS OF THE OFFER

  • 7.1 Authorised Offer(s)

(a) Public Offer: An offer of the Notes may be made, subject to the conditions set out below by the Authorised Offeror(s) (specified in (b) immediately below) other than pursuant to Article 3(2) of the Prospectus Directive in the Public Offer Jurisdiction(s) (specified in (c) immediately below) during the Offer Period (specified in (d) immediately below) subject to the conditions set out in the Base Prospectus and in (e) immediately below.

(b) Name(s) and address(es), to the extent known to the Issuer, of the placers in the various countries where the offer takes place (together, the "Authorised Offeror(s)"):

Each financial intermediary specified in (i) and (ii) below:

  • (i) Specific consent: Not Applicable; and
  • (ii) General consent: Applicable: each financial intermediary which (A) is authorised to make such offers under Directive 2004/39/EC of the European Parliament and of the Council on markets in financial instruments, including under any applicable implementing measure in each relevant jurisdiction, and (B) accepts such offer by publishing on its website the Acceptance Statement.
  • (c) Jurisdiction where the offer may take place (the "Public Offer Jurisdiction"):
  • (d) Offer period for which use of the Base Prospectus is authorised by the Authorised Offeror(s):
  • (e) Other conditions for use of the Base Prospectus by the Authorised Offeror(s):

7.2 Other terms and conditions of the offer

  • (a) Offer Price: The Issue Price
  • (b) Total amount of offer: Aggregate Nominal Amount
  • (c) Conditions to which the offer is subject:

The United Kingdom

Not Applicable

From the open to the close of business on 29 November 2016 (the "Offer Period")

The Issuer reserves the right to withdraw the offer for Securities at any time on or prior to the end of the Offer Period.

Following withdrawal of the offer, if any application has been made by any potential investor, each such potential investor shall not be entitled to subscribe or otherwise acquire the Securities and any applications will be automatically cancelled and any purchase money will be refunded to the applicant by the Authorised Offeror in accordance with the Authorised Offeror's usual procedures.

(d) Time period, including any possible amendments, during which the offer will be open and description of the application process:

(e) Description of the application process:

(f) Details of the minimum and/or maximum amount of application:

  • (g) Description of possibility to reduce subscriptions and manner for refunding excess amount paid by applicants:
  • (h) Details of method and time limits for paying up and delivering the Securities:
  • (i) Manner in and date on which results of the offer are to be made public:
  • (j) Procedure for exercise of any right of pre-emption, negotiability of subscription rights and treatment of subscription rights not exercised:
  • (k) Process for notification to applicants of the amount allotted and indication whether dealing may begin before notification is made:

(l) Amount of any expenses and taxes specifically charged to the subscriber or purchaser:

Investors will be notified by the Authorised Offeror of their allocations of Securities and the settlement arrangements in respect thereof.

An offer of the Securities may be made by the Manager or the Authorised Offeror other than pursuant to Article 3(2) of the Prospectus Directive in the Public Offer Jurisdiction during the Offer Period

Applications for the Securities can be made in the Public Offer Jurisdiction through the Authorised Offeror during the Offer Period. The Securities will be placed into the Public Offer Jurisdiction by the Authorised Offeror. Distribution will be in accordance with the Authorised Offeror's usual procedures, notified to investors by the Authorised Offeror.

The minimum and maximum amount of application from the Authorised Offeror will be notified to investors by the Authorised Offeror.

Not Applicable

Investors will be notified by the Authorised Offeror of their allocations of Securities and the settlement arrangements in respect thereof.

Investors will be notified by the Authorised Offeror of their allocations of Securities and the settlement arrangements in respect thereof.

Not Applicable

Each investor will be notified by the Authorised Offeror of its allocation of Securities at the time of such investor's application.

No dealings in the Securities may take place prior to the Issue Date.

Apart from the Offer Price, the Issuer is not aware of any expenses and taxes specifically charged to the subscriber or purchaser.

Prior to making any investment decision, investors should seek independent professional advice as they deem necessary.

Not Applicable

(m) Name(s) and address(es), to the extent known to the Issuer, of the placers in the various countries where the offer takes place:

SUMMARY

Summaries are made up of disclosure requirements known as 'elements'. These elements are numbered in sections A to E (A.1 to E.7).

Section A – Introduction and warnings
A.1 Introduction
and warnings
This Summary should be read as an introduction to the Base Prospectus.
Any decision to invest in Securities should be based on consideration of the
Base Prospectus as a whole, including any information incorporated by
reference, and read together with the Final Terms.
Where a claim relating to the information contained in the Base Prospectus
is brought before a court, the plaintiff might, under the national legislation
of the relevant Member State of the European Economic Area, have to bear
the costs of translating the Base Prospectus before the legal proceedings are
initiated.
No civil liability shall attach to any responsible person solely on the basis of
this Summary, including any translation thereof, unless it is misleading,
inaccurate or inconsistent when read together with the other parts of the
Base Prospectus or it does not provide, when read together with the other
parts of the Base Prospectus, key information in order to aid holders when
considering whether to invest in the Securities.
A.2 Consent by the
Issuer to the
use of
prospectus in
subsequent
resale or final
placement of
Securities
The Issuer may provide the consent to the use of the Base Prospectus and
Final Terms for subsequent resale or final placement of Securities by
financial intermediaries, provided that the subsequent resale or final
placement of Securities by such financial intermediaries is made during the
offer period specified below. Such consent may be subject to conditions
which are relevant for the use of the Base Prospectus.
The Issuer consents to the use of the Base Prospectus and these Final Terms
with respect to the subsequent resale or final placement of Securities (a
"Public Offer") which satisfies all of the following conditions:
(a)
the Public Offer is only made in the United Kingdom; and
(b)
the Public Offer is only made during the period from the open to the
close of business on 29 November 2016 (the "Offer Period"); and
(c)
the Public Offer is only made by any financial intermediary which (i)
is authorised to make such offers under the Markets in Financial
Instruments
Directive
(Directive
2004/39/EC
of
the
European
Parliament and of the Council) and (ii) has published on its website
that it is using the Base Prospectus in accordance with the Issuer's
consent
and
the
conditions
attached
thereto
(an
"Authorised
Offeror").
Information on the terms and conditions of an offer by any Authorised
Offeror is to be provided at the time of that offer by the Authorised
Offeror.
Section B – Issuer
B.1 Legal and
commercial
name of the
Issuer
The Securities are issued by Barclays Bank PLC (the "Issuer").
The principal laws and legislation under which the Issuer operates are the
the Issuer,
laws of England and Wales including the Companies Act.
legislation
under which
the Issuer
operates and
country of
incorporation
of the Issuer
The business and earnings of the Issuer and its subsidiary undertakings
B.4b
Known trends
(together, the "Bank Group" or "Barclays") can be affected by the fiscal or
affecting the
Issuer and
other policies and other actions of various governmental and regulatory
industries in
authorities in the UK, EU, US and elsewhere, which are all subject to
change. The regulatory response to the financial crisis has led and will
which the
Issuer operates
continue to lead to very substantial regulatory changes in the UK, EU and
US and in other countries in which the Bank Group operates. It has also
(amongst other things) led to (i) a more assertive approach being
demonstrated by the authorities in many jurisdictions; and (ii) enhanced
capital, leverage, liquidity and funding requirements (for example, pursuant
to the fourth Capital Requirements Directive (CRD IV)). Any future
regulatory changes may restrict the Bank Group's operations, mandate
certain lending activity and impose other, significant compliance costs.
Known trends affecting the Issuer and the industry in which the Issuer
operates include:

continuing political and regulatory scrutiny of the banking industry
which is leading to increased or changing regulation that is likely to
have a significant effect on the structure and management of the Bank
Group;

general changes in regulatory requirements, for example, prudential
rules relating to the capital adequacy framework and rules designed to
promote financial stability and increase depositor protection, increased
regulation and procedures for the protection of customers and clients of
financial services firms and an increased willingness on the part of
regulators to investigate past practices, vigorously pursue alleged
violations and impose heavy penalties on financial services firms;

increased levels of legal proceedings in jurisdictions in which the Bank
Group does business, including in the form of class actions;

the US Dodd-Frank Wall Street Reform and Consumer Protection Act,
which contains far-reaching regulatory reform (including restrictions on
proprietary trading and fund-related activities (the so-called 'Volcker
rule');

the United Kingdom Financial Services (Banking Reform) Act 2013
which gives United Kingdom authorities powers to implement measures
for, among others: (i) the separation of the United Kingdom and EEA
retail banking activities of the largest United Kingdom banks into a
legally, operationally and economically separate and independent entity
B.2 Domicile and The Issuer is a public limited company registered in England and Wales.
legal form of
insolvency; and (iii) a 'bail-in' stabilisation option; and
changes in competition and pricing environments.
(so-called
'ring-fencing');
(ii)
statutory
depositor
preference
in
B.5 Description of
the group and
the Issuer's
position within
the group
Barclays is a major global financial services provider.
The whole of the issued ordinary share capital of the Issuer is beneficially
owned by Barclays PLC, which is the ultimate holding company of the Bank
Group.
B.9 Profit forecast
or estimate
Not Applicable: the Issuer has chosen not to include a profit forecast or
estimate.
B.10 Nature of any
qualifications
in audit report
on historical
financial
information
Not Applicable: the audit report on the historical financial information
contains no such qualifications.
B.12 Selected key
financial
information;
no material
adverse change
and no
significant
change
statements
Based on the Bank Group's audited financial information for the year ended
31 December 2015, the Bank Group had total assets of £1,120,727m (2014:
£1,358,693m),
total
net
loans
and
advances
of
£441,046m
(2014:
£470,424m), total deposits of £465,387m (2014: £486,258m), and total
shareholders' equity of £66,019m (2014: £66,045m) (including non
controlling interests of £1,914m (2014: £2,251m)). The profit before tax
from continuing operations of the Bank Group for the year ended 31
December 2015 was £2,841m (2014: £2,309m) after credit impairment
charges and other provisions of £2,114m (2014: £2,168m). The financial
information in this paragraph is extracted from the audited consolidated
financial statements of the Issuer for the year ended 31 December 2015.
Based on the Bank Group's unaudited financial information for the six
months ended 30 June 2016, the Issuer Group had total assets of £1,351,958
million (30 June 2015: £1,197,555 million), total net loans and advances of
£473,962 million (30 June 2015: £475,826 million), total deposits of
£500,919 million (30 June 2015: £494,423 million), and total shareholders'
equity of £69,599 million (30 June 2015: £65,710 million) (including non
controlling interests of £2,976 million (30 June 2015: £2,153 million). The
profit before tax from continuing operations of the Issuer's Group for the six
months ended 30 June 2016 was £3,017 million (30 June 2015: £2,635
million) after credit impairment charges and other provisions of £931
million (30 June 2015: £779 million). The financial information in this
paragraph is extracted from the unaudited consolidated financial statements
of the Issuer for the six months ended 30 June 2016.
Not Applicable. There has been no significant change in the financial or
trading position of the Bank Group since 30 June 2016.
There has been no material adverse change in the prospects of the Issuer
since 31 December 2015.
B.13 Recent events
particular to
the Issuer
which are
materially
relevant to the
evaluation of
Issuer's
solvency
Not Applicable.
B.14
Dependency of
the Issuer on
other entities
within the
The whole of the issued ordinary share capital of the Issuer is beneficially
owned by Barclays PLC, which is the ultimate holding company of the Bank
Group.
group The financial position of the Issuer is dependent on the financial position of
its subsidiary undertakings.
B.15 Description of
the Issuer's
principal
activities
The Bank Group is a major global financial services provider engaged in
retail and commercial banking, credit cards, investment banking, wealth
management and investment management services with an extensive
international presence in Europe, the United States, Africa and Asia.
B.16 Description of
whether the
Issuer is
directly or
indirectly
owned or
controlled and
by whom and
nature of such
control
The whole of the issued ordinary share capital of the Issuer is beneficially
owned by Barclays PLC, which is the ultimate holding company of the
Issuer and its subsidiary undertakings.
Section C – Securities
C.1 Type and class
of Securities
being offered
and/or
admitted to
trading
Securities described in this Summary (the "Securities") are derivative
securities and are issued as notes.
The Securities will not bear interest.
If the Securities have not redeemed early they will redeem on the scheduled
redemption date and the amount paid will be a redemption amount that is
linked to the change in value of one or more specified warrants which may
fluctuate up or down depending on the performance of the reference asset(s)
to which they are linked.
Securities will be cleared through a clearing system and may be held in
bearer form. Certain Securities may be in dematerialised and uncertificated
book-entry form. Title to cleared Securities will be determined by the books
of the relevant clearing system.
Securities will be issued in one or more series (each a "Series") and each
Series may be issued in tranches (each a "Tranche") on the same or
different issue dates. The Securities of each Series are intended to be
interchangeable with all other Securities of that Series. Each Series will be
allocated a unique Series number and an identification code.
The Securities are transferable obligations of the Issuer that can be bought
and sold by investors in accordance with the terms and conditions set out in
the Base Prospectus as completed by the final terms document (the "Final
Terms").
Form: The Securities will initially be issued in global bearer form and may
be exchanged for definitive securities if the clearing system ceases doing
business, or if the Issuer fails to make payments when due.
Identification: Series number: NX000186544; Tranche number: 1
Identification
Codes:
ISIN Code:
XS1452796078; Common
Code:
145279607.
Governing law: The Securities will be governed by English law.
C.2 Currency Subject to compliance with all applicable laws, regulations and directives,
Securities may be issued in any currency.
The Securities will be denominated in pounds sterling ("GBP").
C.5 Description of
restrictions on
free
transferability
of the
Securities
Securities are offered and sold outside the United States to non-US persons
in reliance on 'Regulation S' and must comply with transfer restrictions with
respect to the United States. Securities held in a clearing system will be
transferred in accordance with the rules, procedures and regulations of that
clearing system.
Subject to the above, the Securities will be freely transferable.
C.8 Description of RIGHTS
rights attached
to the
Securities and
limitations to
those rights;
ranking of the
Securities
Each Security includes a right to a potential return and an amount payable
on redemption, together with certain ancillary rights such as the right to
receive notice of certain determinations and events and to vote on future
amendments.
Taxation: All payments in respect of the Securities shall be made without
withholding or deduction for or on account of any UK taxes unless such
withholding or deduction is required by law.
Events of default: If the Issuer fails to make any payment due under the
Securities or breaches any other term and condition of the Securities in a
way that is materially prejudicial to the interests of the holders (and, in each
case, such failure is not remedied within 30 days) or the Issuer is subject to a
winding-up order (other than in connection with a scheme of reconstruction,
merger or amalgamation), the Securities will become immediately due and
payable, upon notice being given by the holder.
LIMITATION TO RIGHTS
Notwithstanding that the Securities are linked to the performance of the
underlying asset(s), Holders do not have any rights in respect of the
underlying assets(s). The terms and conditions of the Securities contain
provisions for calling meetings of holders to consider matters affecting their
interests generally and these provisions permit defined majorities to bind all
holders, including holders who did not attend and vote at the relevant
meeting and holders who voted in a manner contrary to the majority.
Furthermore, in certain circumstances, the Issuer may amend the terms and
conditions of the Securities, without the holders' consent. The terms and
conditions of the Securities permit the Issuer and the Determination Agent
(as the case may be), on the occurrence of certain events and in certain
circumstances, without the holders' consent, to make adjustments to the
terms and conditions of the Securities, to redeem the Securities prior to
maturity, (where applicable) to postpone valuation of the underlying asset(s)
or scheduled payments under the Securities, to change the currency in which
the Securities are denominated, to substitute the Issuer with another
permitted entity subject to certain conditions, and to take certain other
actions with regard to the Securities and the underlying asset(s) (if any).
RANKING
The Securities are direct, unsubordinated and unsecured obligations of the
Issuer and rank equally among themselves.
C.11 Admission to
trading
Securities may be admitted to trading on a regulated market in the United
Kingdom.
Application is expected to be made by the Issuer (or on its behalf) for the
Securities to be admitted to trading on the regulated market of the London
Stock Exchange with effect from 29 November 2016.
C.15 Description of
how the value
of the
investment is
affected by the
The return on, and value of, the Securities will be linked to changes in the
value of the FTSE 100 Index linked Warrants issued by Barclays Bank PLC
(ISIN: GB00B8MNRK12, Series number: NX000186545), the "Underlying
Warrant", the value of which is dependent on the performance of the FTSE
100 Index linked Warrant, the "Underlying Warrant Reference Asset".
value of the
underlying
Interest
instrument The Securities will not bear interest.
Final redemption
The Securities are scheduled to redeem on 29 November 2022 by payment
by the Issuer of an amount in GBP for each GBP 1.00 in nominal amount of
the Securities equal to an amount determined by the Determination Agent in
good faith and in a commercially reasonable manner as GBP 1.00 multiplied
by an amount equal to the value of the Underlying Warrant on 22 November
2022, being the final valuation date, divided by the value of the Underlying
Warrant on 29 November 2016, being the initial valuation date, the final
valuation date being subject to certain delay provisions if any relevant date
for valuation is delayed in accordance with the terms of the Underlying
Warrant.
The greater the value of the Underlying Warrant on the final valuation date
(as compared to the value of the Underlying Warrant on the initial valuation
date), the greater the redemption amount payable on the Securities. If the
value of the Underlying Warrant on the final valuation date is below the
value of the Underlying Warrant on the initial valuation date, the final
redemption amount will be less than the amount invested and could be as
low as zero.
Early redemption
Securities may at the option of the Issuer (in the case of (i) or (ii)) or shall
(in the case of (iii)) be redeemed earlier than the scheduled redemption date
(i) if performance becomes unlawful or physically impracticable, (ii)
following the occurrence of a change in applicable law, a currency
disruption event, an extraordinary market disruption or a tax event affecting
the Issuer's ability to fulfil its obligations under the Securities, or (iii)
following the occurrence of (a) the cancellation or termination of
the
Underlying Warrant (other than by scheduled exercise or automatic exercise
pursuant to its terms) or (b) a specified early cancellation event in respect
thereof.
In each case, the amount due in respect of the Calculation Amount for each
Security will be an amount determined by the Determination Agent in good
faith and in a commercially reasonable manner on the same basis as that
which would have determined the amount due on final redemption except
that the final value in respect of any Underlying Warrant shall be its value as
of the day on which the disruption or termination event, event of default,
unlawfulness or physical impracticability, as the case may be, occurs.
The value of the Underlying Warrant will be published on each Business
Day on GB00B8MNRK12=RIC. Details of the past and future performance
and the volatility of the Underlying Warrant Reference Asset may be
obtained from Reuters page .FTSE.
C.16 Expiration or
maturity date
of the
Securities
The Securities are scheduled to redeem on the scheduled redemption date.
Such scheduled redemption date may be delayed if the determination of any
value used to calculate an amount payable under the Securities is delayed
(including where the valuation of any Underlying Warrant is delayed in
accordance with its terms).
The scheduled redemption date will be 29 November 2022.
C.17 Settlement
procedure of
the derivative
securities
Securities will be delivered on the specified issue date either against
payment of the issue price or free of payment of the issue price of the
Securities. Securities may be cleared and settled through Euroclear,
Clearstream or CREST.
Securities will be delivered on 29 November 2016 (the "Issue Date") free of
payment of the issue price of the Securities.
The Securities are cleared and settled through Euroclear, Clearstream.
C.18 Description of
how the return
on derivative
securities takes
place
The value of and return (if any) on the Securities will be linked to changes in
the value of the Underlying Warrant, the value of which is dependent on the
performance of the Underlying Warrant Reference Asset.
C.19 Final reference
price of the
underlying
The amount payable in respect of the Securities will be calculated using the
value of the Underlying Warrant on 29 November 2016 (the initial valuation
date) and the value of the Underlying Warrant on 22 November 2022 (the
final valuation date).
The value of the Underlying Warrant on the final valuation date will be
determined by the Determination Agent taking into account the applicable
cash or physical settlement amount (as applicable) due on exercise of such
Underlying Warrant.
C.20 Type of
underlying
Securities issued under the Base Prospectus will be derivative securities,
reflecting the fact that the repayment of the Securities will be linked to one
or more underlying warrants, the value of which may fluctuate up or down
depending on the performance of one or more specified reference assets.
Amounts payable on redemption of the Securities will be determined by
reference to the Underlying Warrant (ISIN: GB00B8MNRK12). Information
on
the
Underlying
Warrant
can
be
found
on
http://group.barclays.com/prospectuses-and-documentation/structured
securities/final-terms.
Section D – Risks
D.2 Key
information on
the key risks
that are
specific to the
Issuer
Principal Risks relating to the Issuer: Material risks and their impact are
described below in two sections: (i) Material existing and emerging risks by
Principal Risk and (ii) Material existing and emerging risks potentially
impacting more than one Principal Risk. The five principal risks are
currently categorised as: (1) Credit Risk; (2) Market Risk; (3) Funding Risk;
(4) Operational Risk; and (5) Conduct Risk (within the meaning of the
Issuer's Enterprise Risk Management Framework, each a "Principal Risk").
(i)
Material existing and emerging risks by Principal Risk:
Credit risk: The financial condition of the Group's customers, clients
and
counterparties,
including
governments
and
other
financial
institutions, could adversely affect the Group. The term "Group"
means Barclays PLC together with its subsidiaries. The Group may
suffer financial loss if any of its customers, clients or market
counterparties fails to fulfil their contractual obligations to the Group.
Furthermore, the Group may also suffer loss when the value of the
Group's investment in the financial instruments of an entity falls as a
result of that entity's credit rating being downgraded. In addition, the
Group may incur significant unrealised gains or losses due to changes
in the Group's credit spreads or those of third parties, as these changes
affect the fair value of the Group's derivative instruments, debt
securities that the Group holds or issues, and loans held at fair value.
Market risk: The Group's financial position may be adversely
affected by changes in both the level and volatility of prices leading to
lower revenues, or reduced capital. The Group is also at risk from
movements in foreign currency exchange rates as these impact the
sterling equivalent value of foreign currency denominated assets in the
banking book, exposing it to currency translation risk.
Funding risk: The ability of the Group to achieve its business plans
may be adversely impacted if it does not effectively manage its capital
(including leverage), liquidity and other regulatory requirements. The
Group may not be able to achieve its business plans due to: (i) being
unable to maintain appropriate capital ratios; (ii) being unable to meet
its obligations as they fall due; (iii) rating agency methodology
changes resulting in ratings downgrades; and (iv) adverse changes in
foreign exchange rates on capital ratios.
Operational risk: The operational risk profile of the Group may
change as a result of human factors, inadequate or failed internal
processes and systems, or external events. The Group is exposed to
many types of operational risk. This includes: fraudulent and other
internal and external criminal activities; the risk of breakdowns in
processes, controls or procedures (or their inadequacy relative to the
size and scope of the Group's business); systems failures or an attempt,
by an external party, to make a service or supporting infrastructure
unavailable to its intended users, and the risk of geopolitical cyber
threat activity which destabilises or destroys the Group's information
technology, or critical infrastructure the Group depends upon but does
not control. The Group is also subject to the risk of business disruption
arising from events wholly or partially beyond its control for example
natural disasters, acts of terrorism, epidemics and transport or utility
failures, which may give rise to losses or reductions in service to
customers and/or economic loss to the Group. All of these risks are
also applicable where the Group relies on outside suppliers or vendors
to provide services to it and its customers. The operational risks that
the Group is exposed to could change rapidly and there is no guarantee
that the Group's processes, controls, procedures and systems are
sufficient to address, or could adapt promptly to, such changing risks
to avoid the risk of loss.
Legal,
competition
and
regulatory
matters:
Legal
disputes,
regulatory investigations, fines and other sanctions relating to conduct
of business and financial crime may negatively affect the Group's
results, reputation and ability to conduct its business.
Risks arising from regulation of the financial services industry:
The financial services industry continues to be the focus of significant
regulatory change and scrutiny which may adversely affect the Group's
business,
financial
performance,
capital
and
risk
management
strategies.
Conduct risk:
Organisational Change: The Group is at risk of not being able
to meet customer and regulatory expectations due to a failure to
appropriately manage the: (i) complexity in business practice,
processes
and
systems;
(ii)
challenges
faced
in
product
suitability, automation and portfolio-level risk monitoring; (iii)
resilience of its technology; and, (iv) execution strategy,
including the failure to fulfil the high level of operational
precision required for effective execution in order to deliver
positive customer outcomes.
Legacy Issues: Barclays remains at risk from the potential
outcomes of a number of investigations relating to its past
conduct. Many stakeholders will remain sceptical and so the risk
to Barclays' reputation will remain. Barclays continues to work to
rebuild customer trust and market confidence impacted by legacy
issues.
Market Integrity: There are potential risks arising from
conflicts
of
interest.
While
primarily
relevant
to
the
Investment Bank, these potential risks may also impact the
corporate and retail customer base.
Financial Crime: The Group, as a global financial services firm,
is exposed to the risks associated with money laundering,
terrorist financing, bribery and corruption and sanctions.
Any one, or combination, of the above risks could have
significant impact on the Group's reputation and may also lead to
potentially large costs to both rectify this issue and reimburse
losses incurred by customers and regulatory censure and
penalties.
(ii) Material existing and emerging risks potentially impacting more than
one Principal Risk:
Structural Reform (emerging risk):
The UK Financial Services (Banking Reform) Act 2013 (the UK
Banking Reform Act) and associated secondary legislation and
regulatory rules, require the separation of the Group's UK and EEA
retail and SME deposit-taking activities into a legally, operationally
and economically separate and independent entity and restrict the types
of activity such an entity may conduct (so-called 'ring fencing').
Business conditions, general economy and geopolitical issues:
The Group's performance could be adversely affected in relation to
more than one Principal Risk by a weak or deteriorating global
economy or political instability. These factors may also occur in one or
more of the Group's main countries of operation. The Group offers a
broad range of services to retail, institutional and government
customers, in a large number of countries. The breadth of these
operations means that deterioration in the economic environment, or an
increase in political instability in countries where it is active, or any
other systemically important economy, could adversely affect the
Group's performance.
Business Change/Execution (emerging risk):
As Barclays moves towards a single point of entry (Holding Company)
resolution model and implementation of the Structural Reform
Programme Execution, the expected level of structural and strategic
change to be implemented over the medium term will be disruptive
and is likely to increase funding and operational risks for the Group
and could impact its revenues and businesses.
If any of the risks were to occur, singly or in aggregate, they could
have a material adverse effect on the Group's business, results of
operations and financial condition.
Regulatory action in the event a bank in the Group (such as the Issuer)
is failing or likely to fail could materially adversely affect the value of
the Securities: The Bank Recovery and Resolution Directive (the "BRRD")
provides an EU-wide framework for the recovery and resolution of credit
institutions and investment firms, their subsidiaries and certain holding
companies. The BRRD (including the Bail-In tool) was implemented in the
United Kingdom Banking Act 2009 as amended ("Banking Act") in January
2015 and came into force on 1 January 2016. The Banking Act confers
substantial powers on a number of UK authorities designed to enable them
to take a range of actions in relation to UK banks or investment firms and
certain of their affiliates in the event a bank or investment firm in the same
group is considered to be failing or likely to fail. The exercise of any of
these actions in relation to the Issuer could materially adversely affect the
value of the Securities.
A downgrade of the credit rating assigned by any credit rating agency
to the Issuer could adversely affect the liquidity or market value of the
Securities. Credit ratings downgrade could occur as a result of, among
other causes, changes in the ratings methodologies used by credit rating
agencies. Changes in credit rating agencies' views of the level of implicit
sovereign support for European banks and their groups are likely to
lead to credit ratings downgrades.
The Issuer is affected by risks affecting the Group: The Issuer is also
affected by risks affecting the Group as there is substantial overlap in the
businesses of the Issuer and its subsidiaries. Further, the Issuer can be
negatively affected by risks and other events affecting its subsidiaries even
where the Issuer is not directly affected.
D.6 Key
information on
You may lose up to the entire value of your investment if the Issuer fails
or is otherwise unable to meet its payment obligations.
the key risks
that are
You may also lose the value of your investment if:
specific to the
Securities; and
risk warning
that investors
may lose some
or all of the
the Underlying Warrant(s) (or the Underlying Warrant Reference

Asset(s) and in turn the Underlying Warrant(s)) perform in such a
manner that the redemption amount payable to you (whether at
maturity or following an early redemption) is less than the initial
purchase price and could be as low as zero;
value of their
investment
you sell your Securities prior to maturity in the secondary market (if
any) at an amount that is less than the initial purchase price; and/or
the Securities are redeemed early following the occurrence of an

extraordinary event in relation to the Underlying Warrant, the Issuer,
the relevant currencies or taxation (such as following an additional
disruption event) and the amount you receive on such early redemption
is less than the initial purchase price.
Risk of withdrawal of the public offering: In case of a public offer, the
Issuer may provide in the Final Terms that it is a condition of the offer that
the Issuer may withdraw the offer for reasons beyond its control, such as
extraordinary events that in the determination of the Issuer may be
prejudicial to the offer. In such circumstances, the offer will be deemed to be
null and void. In such case, where you have already paid or delivered
subscription monies for the relevant Securities, you will be entitled to
reimbursement of such amounts, but will not receive any remuneration that
may have accrued in the period between their payment or delivery of
subscription monies and the reimbursement of the Securities.
Reinvestment risk/loss of yield: Following an early redemption of your
Securities for any reason, you may be unable to reinvest the redemption
proceeds at an effective yield as high as the yield on the Securities being
redeemed.
Volatile market prices: The market value of the Securities is unpredictable
and may be highly volatile, as it can be affected by many unpredictable
factors, including: market interest and yield rates; fluctuations in currency
exchange rates; exchange controls; the time remaining until the Securities
mature; economic, financial, regulatory, political, terrorist, military or other
events in one or more jurisdictions; changes in laws or regulations; the
Issuer's creditworthiness or perceived creditworthiness; and the performance
of the relevant Underlying Warrant(s) (or the Underlying Warrant Reference
Asset(s) and in turn the Underlying Warrant(s)).
Securities are not 'principal protected': Upon maturity of your Securities,
you may lose some or all of the capital that you invested, depending on the
performance of the Underlying Warrant(s) (or the Underlying Warrant
Reference Asset(s) and in turn the Underlying Warrant(s)).
Securities include embedded derivatives on Underlying Asset(s) that are
subject to adjustment:
The Securities are linked to the Underlying
Warrant(s) which are in turn linked to the Underlying Warrant Reference
Asset(s). The Underlying Warrant(s) are subject to provisions which provide
for adjustments and modifications of their terms and alternative means of
valuation of the Underlying Warrant Reference Asset(s) in certain
circumstances (and which could be exercised by the issuer of the Underlying
Warrant(s) in a manner which has an adverse effect on the market value
and/or amount repayable in respect of your Securities).
Risks relating to Underlying Warrants: You are exposed to the change in
value of the Underlying Warrant(s) which may fluctuate up or down
depending on the performance of the Underlying Warrant Reference
Asset(s). The performance of the Underlying Warrant Reference Asset(s)
may be subject to fluctuations that may not correlate with other similar
reference assets. Payments upon redemption will be calculated by the
change in value of the Underlying Warrant(s) between 29 November 2016
and 22 November 2022. Any information about the past performance of the
Underlying Warrant(s) and/or the Underlying Warrant Reference Asset(s)
should not be taken as an indication of how prices will change in the future.
You should also note that the market value of both your Securities and the
Underlying Warrant(s) will be affected by the ability, and the perceived
ability, of the Issuer to fulfil its obligations under the instruments. The
impact of any inability, or perceived inability, of the Issuer in this regard
may be greater in respect of the Securities as the Securities are linked to
Underlying Warrant(s) that are issued by the Issuer and it may negatively
affect both the value of the Underlying Warrant(s) and the value of your
Securities.
Risks associated with specific Underlying Warrant Reference Asset(s):
As the Underlying Warrant Reference Asset is an equity index, the
Underlying Warrant may be subject to the risk of fluctuations in market
interest rates, currency exchange rates, equity prices, commodity prices,
inflation, the value and volatility of the relevant equity index, and also to
economic, financial, regulatory, political, terrorist, military or other events
in one or more jurisdictions, including factors affecting capital markets
generally or the stock exchanges on which any such Underlying Warrant
may be traded. This could have an adverse effect on the value of the
Underlying Warrant which, in turn, will have an adverse effect on the value
of your Securities.
The capital invested in the Securities is at risk. Consequently, you may lose
the value of your entire investment, or part of it.
Section E – Offer
E.2b Reasons for
offer and use of
proceeds when
different from
making profit
and/or hedging
certain risks
The net proceeds from each issue of Securities will be applied by the Issuer
for its general corporate purposes, which include making a profit and/or
hedging certain risks. If the Issuer elects at the time of issuance of Securities
to make different or more specific use of proceeds, the Issuer will describe
that use in the Final Terms.
E.3 Description of
the terms and
conditions of
the offer
The terms and conditions of any offer of Securities to the public may be
determined by agreement between the Issuer and the Manager(s) at the time
of each issue.
The Securities are offered subject to the following conditions:
Offer Price: 100% of the Issue Price
Conditions to which the offer is subject: The Issuer reserves the right to
withdraw the offer for Securities at any time on or prior to the end of the
Offer Period.
Following withdrawal of the offer, if any application has been made by any
potential investor, each such potential investor shall not be entitled to
subscribe or otherwise acquire the Securities and any applications will be
automatically cancelled and any purchase money will be refunded to the
applicant by the Authorised Offeror in accordance with the Authorised
Offeror's usual procedures.
Description of the application process: An offer of the Securities may be
made by the Manager or the Authorised Offeror other than pursuant to
Article 3(2) of the Prospectus Directive in the United Kingdom (the "Public
Offer Jurisdiction") during the Offer Period.
Applications for the Securities can be made in the Public Offer Jurisdiction
through the Authorised Offeror during the Offer Period. The Securities will
be placed into the Public Offer Jurisdiction by the Authorised Offeror.
Distribution will be in accordance with the Authorised Offeror's usual
procedures, notified to investors by the Authorised Offeror.
Details of the minimum and/or maximum amount of application: The
minimum and maximum amount of application from the Authorised Offeror
will be notified to investors by the Authorised Offeror.
Description of possibility to reduce subscriptions and manner
for
refunding excess amount paid by applicants: Not Applicable
Details of the method and time limits for paying up and delivering the
Securities: The Issue Date
Manner in and date on which results of the offer are to be made public:
Investors will be notified by the Authorised Offeror of their allocations of
Securities and the settlement arrangements in respect thereof.
Procedure for exercise of any right of pre-emption, negotiability of
subscription rights and treatment of subscription rights not exercised:
Not Applicable
Process for notification to applicants of the amount allotted and
indication whether dealing may begin before notification is made: Each
investor will be notified by the Authorised Offeror of its allocation of
Securities at the time of such investor's application.
Amount of any expenses and taxes specifically charged to the subscriber
or purchaser: Apart from the Offer Price, the Issuer is not aware of any
expenses and taxes specifically charged to the subscriber or purchaser. Prior
to making any investment decision, investors should seek independent
professional advice as they deem necessary
Name(s) and address(es), to the extent known to the Issuer, of the
placers in the various countries where the offer takes place:
Not
Applicable
E.4 Description of
any interest
material to the
issue/offer,
including
conflicting
interests
The relevant Manager(s) or authorised offeror(s) may be paid fees in relation
to any issue or offer of Securities. Potential conflicts of interest may exist
between the Issuer, Determination Agent, relevant Manager(s) or authorised
offeror(s) or their affiliates (who may have interests in transactions in
derivatives related to the Underlying Asset(s) which may, but are not
intended to, adversely affect the market price, liquidity or value of the
Securities) and holders.
E.7 Estimated The Issuer will not charge any expenses to holders in connection with any
expenses
charged to
investor by
issue of Securities. Offerors may, however, charge expenses to holders.
Such expenses (if any) will be determined by agreement between the offeror
and the holders at the time of each issue.
issuer/offeror Not Applicable: no expenses will be charged to the holder by the issuer or
the offeror(s).